Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 2018

View Archived Issues

Pfizer reflects on milestones of fourth quarter 2017

EMA accepts fremanezumab MAA

Celgene begins tender offer for Juno Therapeutics

Takeda describes novel Toll-like receptor 4 antagonists

SYT7 identifies gastric cancer with hepatic metastasis

Novo Nordisk updates events of fourth quarter 2017

Astellas Pharma, Pfizer support research into role of AR in breast cancer

Shanghai Synergy initiates phase I/II study in China with hypidone in major depressive disorder

Phase III AEGIS-CKD study of Feraccru does not meet primary endpoint

NEOLAP trial interim results presented for patients with LAPC

A1M Pharma seeks Swedish clearance to begin phase I study of ROSgard

ReViral reports promising outcome from phase IIa challenge study of RV-521 in RSV

Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer

Amgen discovers new sodium channel blockers

Novel beta-glucuronidase inhibitors patented by UNC Chapel Hill

Latvian Institute of Organic Synthesis presents seleopheno[h]chromene derivatives

PTGDR2 antagonists patented by Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery

High rate of response seen with nivolumab/nab-paclitaxel treatment in PDAC

Asahi Kasei launches Kevzara in Japan

FDA grants orphan drug designation to Hanmi's LAPS glucagon analogue

Vancomycin-based vancapticins overcome Gram-positive bacterial resistance

Palatin initiates phase I study of melanocortin MC1 receptor agonist PL-8177

CtBP2 and CD44 found useful for risk stratification of GIST patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...